PetMed Express Inc (PETS)
4.645
+0.06
(+1.42%)
USD |
NASDAQ |
Nov 21, 16:00
4.645
0.00 (0.00%)
After-Hours: 20:00
PetMed Express Revenue (Quarterly): 59.57M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 59.57M |
| June 30, 2024 | 67.95M |
| March 31, 2024 | 66.50M |
| December 31, 2023 | 65.32M |
| September 30, 2023 | 71.00M |
| June 30, 2023 | 78.24M |
| March 31, 2023 | 62.41M |
| December 31, 2022 | 58.87M |
| September 30, 2022 | 65.39M |
| June 30, 2022 | 70.04M |
| March 31, 2022 | 64.87M |
| December 31, 2021 | 60.72M |
| September 30, 2021 | 67.39M |
| June 30, 2021 | 79.31M |
| March 31, 2021 | 66.05M |
| December 31, 2020 | 65.90M |
| September 30, 2020 | 75.44M |
| June 30, 2020 | 96.20M |
| March 31, 2020 | 74.29M |
| December 31, 2019 | 59.92M |
| September 30, 2019 | 69.94M |
| June 30, 2019 | 79.99M |
| March 31, 2019 | 64.56M |
| December 31, 2018 | 60.07M |
| September 30, 2018 | 71.40M |
| Date | Value |
|---|---|
| June 30, 2018 | 87.39M |
| March 31, 2018 | 67.32M |
| December 31, 2017 | 60.11M |
| September 30, 2017 | 66.71M |
| June 30, 2017 | 79.66M |
| March 31, 2017 | 63.03M |
| December 31, 2016 | 52.87M |
| September 30, 2016 | 60.79M |
| June 30, 2016 | 72.49M |
| March 31, 2016 | 55.39M |
| December 31, 2015 | 50.93M |
| September 30, 2015 | 56.72M |
| June 30, 2015 | 71.63M |
| March 31, 2015 | 49.99M |
| December 31, 2014 | 49.28M |
| September 30, 2014 | 57.58M |
| June 30, 2014 | 72.54M |
| March 31, 2014 | 48.63M |
| December 31, 2013 | 50.09M |
| September 30, 2013 | 60.48M |
| June 30, 2013 | 74.19M |
| March 31, 2013 | 51.12M |
| December 31, 2012 | 49.61M |
| September 30, 2012 | 58.14M |
| June 30, 2012 | 68.96M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
58.87M
Minimum
Dec 2022
96.20M
Maximum
Jun 2020
68.77M
Average
66.28M
Median
Revenue (Quarterly) Benchmarks
| TruBridge Inc | 83.83M |
| Streamline Health Solutions Inc | 4.476M |
| R1 RCM Inc | 656.80M |
| LENZ Therapeutics Inc | -- |
| Oruka Therapeutics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.326M |
| Total Expenses (Quarterly) | 59.02M |
| EPS Diluted (Quarterly) | 0.11 |
| Enterprise Value | 42.60M |
| Gross Profit Margin (Quarterly) | 29.06% |
| Profit Margin (Quarterly) | 3.90% |
| Earnings Yield | -1.29% |
| Normalized Earnings Yield | -1.292 |